Anjali S. Advani

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies”.

Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-3706

N/A

4.4DataRank · unranked

198 citations

Michael B. Maris, Alexander M. Lesokhin, Robert W. Chen, Ian W. Flinn, Ahmed Sawas +21 more

Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults

New England Journal of Medicine(2024)10.1056/nejmoa2312948

N/A

4.4DataRank · unranked

227 citations

Zhuoxin Sun, Ryan J. Mattison, Elisabeth Paietta, Kathryn G. Roberts, Yanming Zhang +37 more

Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

Blood(2020)10.1182/blood.2020007732

N/A

4.0DataRank · unranked

322 citations

Ibrahim Aldoss, Matthew C. Foster, Peter H. Sayre, Matthew J. Wieduwilt, Anjali S. Advani +43 more

Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia

Blood Advances(2022)10.1182/bloodadvances.2022008216

N/A

1.8DataRank · unranked

72 citations

Anna Moseley, Kristen M. O’Dwyer, Brent L. Wood, Jae H. Park, Matthew J. Wieduwilt +12 more

Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: analysis from CALGB 10403 and the CIBMTR

Leukemia(2021)10.1038/s41375-021-01213-5

N/A

0.564DataRank · unranked

42 citations

Wendy Stock, Anjali S. Advani, Selina M. Luger, Richard A. Larson, Martin S. Tallman +22 more

CAR HEMATOTOX independently predicts outcomes after CD19 CAR-T therapy for acute lymphoblastic leukemia

Blood Advances(2025)10.1182/bloodadvances.2025017526

N/A

0.267DataRank · unranked

3 citations

Chenyu Lin, David Nemirovsky, Sean Devlin, Kai Rejeski, Kevin J. Curran +43 more

Comparison of chemotherapy dose intensity for AYAs on COG AALL1131 versus CALGB 10403.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.10520

N/A

0.104DataRank · unranked

1 citations

Lingyun Ji, Xinxin Xu, Michael J. Burke, Wanda L. Salzer, Meenakshi Devidas +10 more

Data from Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

(2023)10.1158/1078-0432.c.6531017

N/A

0DataRank · unranked

0 citations

Michael B. Maris, Alexander M. Lesokhin, Robert W. Chen, Ian W. Flinn, Ahmed Sawas +21 more

Biobanking and consent to future biospecimen use among adults enrolled in SWOG trials from 2000 to 2024

Blood Cancer Journal(2025)10.1038/s41408-025-01294-w

N/A

0DataRank · unranked

2 citations

Alexis Berridge-Green, Megan Othus, Jerald P. Radich, Anjali S. Advani, Harry P. Erba +2 more

TP53 abnormalities correlate with immune infiltration and associate with response to flotetuzumab immunotherapy in AML

Blood Advances(2020)10.1182/bloodadvances.2020002512

N/A

0DataRank · unranked

154 citations

Catherine Lai, Stephen Reeder, S. Church, Tressa Hood, Anbarasu Lourdusamy +24 more

Disparities in real-world treatment patterns of hypomethylating agents among patients with MDS in the United States

Blood Neoplasia(2025)10.1016/j.bneo.2025.100156

N/A

0DataRank · unranked

1 citations

Weichuan Dong, Aaron T. Gerds, Hetty E. Carraway, Abhay Singh, Anjali S. Advani +9 more

Distinctive and common features of moderate aplastic anaemia

British Journal of Haematology(2020)10.1111/bjh.16460

N/A

0DataRank · unranked

23 citations

Shimoli V. Barot, Teodora Kuzmanovic, Cassandra M Kerr, Bartlomiej Przychodzen, Swapna Thota +10 more

Association of immunophenotype with expression of topoisomerase II α and β in adult acute myeloid leukemia

Scientific Reports(2020)10.1038/s41598-020-62345-9

N/A

0DataRank · unranked

4 citations

Shannon McDonough, Cheryl L. Willman, Eric R. Koegle, John E. Godwin, Stephen H. Petersdorf +8 more

Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia

Blood(2021)10.1182/blood.2020010603

N/A

0DataRank · unranked

80 citations

Arda Durmaz, Carmelo Gurnari, Ashwin Kishtagari, Manja Meggendorfer, Cassandra M Kerr +19 more

Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes

The Oncologist(2023)10.1093/oncolo/oyad114

N/A

0DataRank · unranked

3 citations

Weichuan Dong, Nicholas K. Schiltz, Kurt C. Stange, Jennifer Cullen, Aaron T. Gerds +6 more

SINGLE CELL DISSECTION OF DEVELOPMENTAL ORIGINS AND TRANSCRIPTIONAL HETEROGENEITY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.04.569954

N/A

0DataRank · unranked

17 citations

Andy G.X. Zeng, Qingsong Gao, Laura García‐Prat, Pradyuamna Baviskar, Sayyam Shah +20 more

Data from Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies

(2023)10.1158/1078-0432.c.6531017.v1

N/A

0DataRank · unranked

0 citations

Michael B. Maris, Alexander M. Lesokhin, Robert W. Chen, Ian W. Flinn, Ahmed Sawas +21 more